The investigation concerns whether Amedisys and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders by failing to, among other things: (1) obtain the best possible consideration for Amedisys shareholders; (2) determine whether Option Care is underpaying for Amedisys; and (3) disclose all material information necessary for Amedisys shareholders to adequately assess and value the merger consideration. On behalf of Amedisys shareholders, Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits.